// App-Quantinova.ai

: Safety and efficacy of IV cladribine versus alemtuzumab in aggressive multiple sclerosis: a retrospective cohort study (P1.368)

Researchers

Presenter

  • Gauruv Bose

Principal Investigators

  • Mark Freedman

  • Carolina Rush

  • Marjorie Bowman

  • Harold Atkins

Medical Centers

  • 1Neurology, The University of Ottawa Ottawa ON Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Alemtuzumab

  • Cladribine

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved